ΑΓΓΕΛΟΣ Μ. ΛΙΟΝΤΟΣ

ΕΙΔΙΚΟΣ ΠΑΘΟΛΟΓΟΣ

MD, MSc, PhD, FEFIM

τέως Επιμελητής ΕΣΥ, 
Α΄ Παθολογικής Κλινικής ΠΓΝΙ

ΔΥΣΛΙΠΙΔAIΜΙΑ

  1. EUROPEAN SOCIETY OF ATHEROSCLEROSIS (EAS) – FOLLOWING EXAMINATION: Angelos Liontos has been awarded the EAS Certificate of Excellence in Lipidology 2023 Update (ELM23-A00075) (accredited by the EACCME®, the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.
  2. EUROPEAN SOCIETY OF ATHEROSCLEROSIS (EAS) – FOLLOWING EXAMINATION:Angelos Liontos has been awarded theEAS Certificate of Excellence in Lipidology (2021 Update) (ELM19-A00022) (accredited by the EACCME®, the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.
  3. AMERICAN HEART ASSOCIATION (AHA) – FOLLOWING EXAMINATION: Certificate of Completion The American Heart Association certifies that Angelos Liontos has participated in the educational activity titled Lipoprotein(a): Add Peripheral Artery Disease tothe List of Targets – Certificate of Credit The American Heart Association certifies that Angelos Liontos MSc, PhD has participated in the enduring material titled Lipoprotein(a): Add Peripheral Artery Disease to the List of Targets. This activity has been planned and implemented by the American Heart Association
  4. AMERICAN HEART ASSOCIATION (AHA) – FOLLOWING EXAMINATION: Certificate of Completion The American Heart Association certifies that Angelos Liontos has participated in the educational activity titled Lipoprotein(a): An Atherosclerotic Cardiovascular Disease (ASCVD) Risk Factor That Can No Longer Be Ignored– Certificate of Credit The American Heart Association certifies that Angelos Liontos MSc, PhD has participated in the enduring material titled Lipoprotein(a): An Atherosclerotic Cardiovascular Disease (ASCVD) Risk Factor That Can No Longer Be Ignored. This activity has been planned and implemented by the American Heart Association
  5. AMERICAN HEART ASSOCIATION (AHA) – FOLLOWING EXAMINATION: Certificate of Completion The American Heart Association certifies that Angelos Liontos has participated in the educational activity titled Identify & Manage Lp(a). This activity has been planned and implemented by the American Heart Association
  6. International Atherosclerosis Society (ISA): Angelos Liontos has completed the course from IAS eLearning Center (IASEC): Severe Dyslipidemias in LATAM: Confronting the Future
  7. EUROPEAN SOCIETY OF ATHEROSCLEROSIS (EAS) CERTIFICATE OF ATTENDANCE: Angelos Liontos has taken part in the Course: CLINICAL LIPIDOLOGY, FURTHER PERSPECTIVES
  8. EUROPEAN SOCIETY OF ATHEROSCLEROSIS (EAS) and NATIONAL LIPID ASSOCIATION (NLA)CERTIFICATE OF ATTENDANCE: Angelos Liontos has taken part and completed all modules in the Course: Dyslipidemia Treatment in Light of the New Guidelines
  9. EUROPEAN SOCIETY OF CARDIOLOGY (ESC) – FOLLOWING EXAMINATION: CERTIFICATE (European Accreditation Council for Continuing Medical Education EACCME) Angelos Liontos has completed the course from European Society of Cardiology (ESC) e-learning: 2019 – Guidelines on Dyslipidaemias (Management of)
  10. Ειδικευόμενος Ιατρός Εσωτερικής Παθολογίας, στη ΄Β Παθολογική Κλινική του Πανεπιστημιακού Γενικού Νοσοκομείου Ιωαννίνων: 08/10/2014 – 24/07/2019 – Εκπαίδευση στα πλαίσια Εξωτερικού Ιατρείου Διαταραχών του Μεταβολισμού των Λιπιδίων και Παχυσαρκίας του Πανεπιστημιακού Γενικού Νοσοκομείου Ιωαννίνων
  11. Επιστημονικός Συνεργάτης της ΄Β Παθολογικής Κλινικής και του Εξωτερικού Ιατρείου Διαταραχών του Μεταβολισμού των Λιπιδίων και Παχυσαρκίας του Πανεπιστημιακού Γενικού Νοσοκομείου Ιωαννίνων, 01/04/2013 έως 31/01/2020

Άγγελος Μ. Λιόντος

Ειδικός Παθολόγος, MD, MSc, PhD, FEFIM
τέως Επιμελητής Α’ Παθολογικής ΠΓΝΙ

Για ραντεβού

Ώρες λειτουργίας Ιατρείου